Multivariable Prognostic Score to Guide Systemic Therapy in Early-Stage HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multivariable Prognostic Score to Guide Systemic Therapy in Early-Stage HER2-Positive Breast Cancer: A Retrospective Study With an External Evaluation
Lancet Oncol 2020 Nov 01;21(11)1455-1464, A Prat, V Guarneri, L Paré, G Griguolo, T Pascual, MV Dieci, N Chic, B González-Farré, A Frassoldati, E Sanfeliu, JM Cejalvo, M Muñoz, G Bisagni, F Brasó-Maristany, L Urso, M Vidal, AA Brandes, B Adamo, A Musolino, F Miglietta, B Conte, M Oliveira, C Saura, S Pernas, J Alarcón, A Llombart-Cussac, J Cortés, L Manso, R López, E Ciruelos, F Schettini, P Villagrasa, LA Carey, CM Perou, F Piacentini, R D'Amico, E Tagliafico, JS Parker, P ConteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.